GOLDMAN SACHS GROUP INC

Position in NVS — Novartis AG

CIK 886982 NEW YORK, NY

Back to NVS Full portfolio

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$467,051,927

-$529,759,591 QoQ

Shares Held

2,980,168

-54.3% QoQ

Ownership

0.157%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

of 1,603 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 90% Shared 0% None 10%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Derivatives in NVS

reported options exposure · as of Sep 30, 2021

CallValue

$441,612

CallShares

5,400

PutValue

$915,936

PutShares

11,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $29,799,350,964 across 16 Drug Manufacturers - General names. NVS ranks #10 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	7,652,960	$9,179,190,573
2	JNJ	Johnson & Johnson	19,722,544	$5,008,934,496
3	ABBV	AbbVie Inc.	16,291,630	$4,099,625,769
4	MRK	Merck & Co., Inc.	22,075,139	$2,836,655,359
5	AZN	Astrazeneca PLC	9,742,396	$1,847,353,128
6	AMGN	Amgen Inc	4,130,732	$1,495,820,670
7	GILD	Gilead Sciences, Inc.	10,778,294	$1,361,729,661
8	PFE	Pfizer Inc	52,991,850	$1,276,043,746

All Filings in NVS

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$467,051,927	2,980,168	-54.3%	Shares	Defined	2026-08-14
2026-03-31	$996,811,518	6,525,771	+137.7%	Shares	Defined	2026-05-15
2025-12-31	$378,514,363	2,745,444	-6.9%	Shares	Defined	2026-03-25
2025-09-30	$378,262,730	2,949,647	+16.0%	Shares	Defined	2025-11-14
2025-06-30	$307,591,929	2,541,872	-30.6%	Shares	Defined	2025-08-14
2025-03-31	$408,070,866	3,660,485	+60.3%	Shares	Defined	2025-06-27
2024-12-31	$222,181,401	2,283,233	-34.5%	Shares	Defined	2025-02-11
2024-09-30	$400,986,288	3,486,231	+13.1%	Shares	Defined	2024-11-14
2024-06-30	$328,011,350	3,081,076	+0.7%	Shares	Defined	2024-08-13
2024-03-31	$295,931,988	3,059,361	-13.5%	Shares	Defined	2024-05-15
2023-12-31	$357,020,023	3,535,902	+27.4%	Shares	Defined	2024-05-14
2023-09-30	$282,596,002	2,774,357	-4.2%	Shares	Defined	2024-05-15
2023-06-30	$292,383,091	2,897,464	-37.6%	Shares	Defined	2024-05-14
2023-03-31	$427,374,868	4,645,379	+147.6%	Shares	Defined	2024-05-14
2022-12-31	$170,236,351	1,876,503	-30.1%	Shares	Defined	2024-05-14
2022-09-30	$204,122,040	2,685,463	+1.9%	Shares	Defined	2024-05-14
2022-06-30	$222,764,611	2,635,332	-5.3%	Shares	Defined	2024-05-14
2022-03-31	$244,085,047	2,781,596	+27.2%	Shares	Defined	2022-05-16
2021-12-31	$191,332,050	2,187,402	+5.2%	Shares	Defined	2022-02-17
2021-09-30	$441,612	5,400	0.0%	Call	Defined	2022-01-20
2021-09-30	$915,936	11,200	0.0%	Put	Defined	2022-01-20
2021-09-30	$169,976,948	2,078,466	-9.1%	Shares	Defined	2022-01-20
2021-06-30	$208,664,601	2,286,986	-15.0%	Shares	Defined	2021-08-13
2021-06-30	$1,021,888	11,200	-30.0%	Put	Defined	2021-08-13
2021-06-30	$492,696	5,400	0.0%	Call	Defined	2021-08-13
2021-03-31	$1,367,680	16,000	-46.7%	Put	Defined	2021-05-17
2021-03-31	$229,903,161	2,689,555	+65.1%	Shares	Defined	2021-05-17
2021-03-31	$461,592	5,400	-89.2%	Call	Defined	2021-05-17
2020-12-31	$153,821,559	1,628,948	-6.2%	Shares	Defined	2021-02-12
2020-09-30	$4,348,000	50,000	-69.9%	Call	Defined	2020-11-13
2020-09-30	$2,608,800	30,000	-3.8%	Put	Defined	2020-11-13
2020-09-30	$151,050,127	1,737,007	+11.6%	Shares	Defined	2020-11-13
2020-06-30	$2,725,008	31,200	+47.2%	Put	Defined	2020-08-12
2020-06-30	$14,507,174	166,100	-10.6%	Call	Defined	2020-08-12
2020-06-30	$135,960,779	1,556,684	-1.8%	Shares	Defined	2020-08-12
2020-03-31	$1,747,940	21,200	—	Put	Defined	2020-05-15
2020-03-31	$15,310,965	185,700	—	Call	Defined	2020-05-15
2020-03-31	$130,656,453	1,584,675	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.